Updated: IPEC Federation Questionnaire for Excipient Nitrosamines Risk Evaluation
IPEC Federation announces the availability of the updated “Questionnaire for Excipient Nitrosamines Risk Evaluation” (version 2, 2025).
IPEC Federation announces the availability of the updated “Questionnaire for Excipient Nitrosamines Risk Evaluation” (version 2, 2025).
In the issue:
Updates from the latest publications, our participation in events and workshops, and news from the regional IPECs.
IPEC Federation statement on the ‘WHO–UNODC Report on Contaminated Medicines and Integrity of the Pharmaceutical Excipients Supply Chain
A position paper that explains the various excipient GMP guides and standards supported by IPEC Federation.
IPEC Federation announces the availability of the IPEC Risk Assessment Guide for Pharmaceutical Excipients – Risk Assessment for Excipient Manufacturers.
Welcome to 2025’s first issue of IPEC Federation Connect.
In this edition, we present the priority objectives for this year and regional updates from our five regional IPEC members.
IPEC Federation announces the availability of the updated IPEC Incorporation of Pharmaceutical Excipients into Product Development using Quality-by-Design (QbD) (Version 2, 2025).
IPEC Federation announces the availability of an updated position paper on Third Party Audit and Certification Programmes
Welcome to the second and final issue of the year of the IPEC Federation bulletin. In this edition, we provide you with updates from the latest publications, our participation to events and workshops, and news from the regional IPECs.
IPEC Federation announces the availability of the updated IPEC Good Distribution Practices (GDP) for Pharmaceutical Excipients.